Behrman Capital to Acquire Athena Diagnostics from Elan Pharmaceuticals
NEW YORK, November 22, 2002 — Behrman Capital, a private equity investment firm based in New York and San Francisco, announced today that it has signed a definitive agreement to acquire Athena Diagnostics, Inc. (“Athena Diagnostics”), a leading commercial diagnostic…